Product Information
Name:Brolucizumab
Synonyms:
- RTH258
- ESBA 1008
- DLX1008
Brand:Targetmol
Description:Brolucizumab (anti-VEGF-A scFv) potently blocks VEGF-A to reduce neovascularization in wet AMD, with picomolar binding affinity.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Purity:95%
Color/Form:Liquid
Technical inquiry about: Brolucizumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.